Judy Murrah, Applied DNA Sciences Counterfeit drug products are a major problem for the pharmaceutical industry. This article discusses how DNA molecular taggants can help combat drug counterfeiting and improve the safety of the pharmaceutical supply chain.
On track: An exclusive licensing agreement will light up the world’s first DNA-based cannabis-tagging system. FEBRUARY 14, 2019 By GREGORY ZELLER // A partnership between a Stony Brook biotech and a Canadian pharmaceutical-solutions provider is growing like a weed. Less than a year since introducing the world’s first DNA-based cannabis-tagging system and just [...]
By Victor Ocasio Applied DNA Sciences, a Stony Brook-based biotechnology company, has entered a $5 million nonbinding licensing agreement with a Canadian cannabis consultancy that will use the Long Island firm’s “molecular tagging” technology in the marijuana industry.
Applied DNA Signs Term Sheet with TheraCann International for Exclusive License of CertainT Platform in Legal Cannabis and Hemp
STONY BROOK, N.Y., and PANAMA CITY, PANAMA (February 12, 2019) – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA,” or “the Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, and TheraCann International Benchmark Corporation (“TheraCann”), a leading global full-service legal cannabis and hemp consultancy, announced today that they have entered [...]
STONY BROOK, N.Y. February 7, 2019 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced financial results for the fiscal 2019 first quarter ended December 31, 2018. “Our performance for the quarter reflects a consistent year-over-year foundation to our cotton business and continued execution under our multi-year contracts with the [...]
Joint Applied DNA/TheraCann’s Cannabis Seed-to-Sale Solution Positioned Towards Europe, Africa and Asia Markets by Israel Cannabis (iCAN)
STONY BROOK, N.Y., February 6, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in large-scale PCR-based DNA manufacturing, announced today that two prior announcements by Israel Cannabis raise the opportunity for uptake of Applied DNA’s CertainT® Cannabis Tagging platform within the Israeli cannabis industry. Central to the [...]
Applied DNA's recently-signed MOU with Tex-Ray Industrial Co. aims to introduce the CertainT Authentication Platform to global textile brands. Both brands will create a Center of Excellence in Taiwan. The Center of Excellence will: Integrate CertainT's tag, test and track platform into yarns, finishes and fabrics Design streamlined supply chain processes to [...]
Applied DNA Sciences uses a system of molecular tagging to assign a secure identity to products and materials. Their molecular DNA-based identification system is versatile and can be deployed and verified at any point in the supply chain. Starting out as a cash security technology, Applied DNA’s process has been tested [...]
Spanning the globe: Stony Brook-based Applied DNA Sciences continues its world tour with a new Memorandum of Understanding in Taiwan. FEBRUARY 4, 2019 By GREGORY ZELLER Look out, Asia – here comes Applied DNA Sciences. Picking up where it left off at the end of a hyper-busy 2018 – in which it expanded [...]
Applied DNA and Sun Chemical Supply have formed a strategic alliance to broaden Applied DNA's presence in Asia, enabling the adoption of the CertainT platform across textiles, footwear, accessories and component value chains. The multi-dimensional, non-exclusive strategic alliance outlined in the MOU will also enable Sun Chemical Supply to provide value-added services, [...]